Literature DB >> 21300461

Volumetric-modulated arc therapy for stereotactic body radiotherapy of lung tumors: a comparison with intensity-modulated radiotherapy techniques.

Andrea Holt1, Corine van Vliet-Vroegindeweij, Anton Mans, José S Belderbos, Eugène M F Damen.   

Abstract

PURPOSE: To demonstrate the potential of volumetric-modulated arc therapy (VMAT) compared with intensity-modulated radiotherapy (IMRT) techniques with a limited number of segments for stereotactic body radiotherapy (SBRT) for early-stage lung cancer. METHODS AND MATERIALS: For a random selection of 27 patients eligible for SBRT, coplanar and noncoplanar IMRT and coplanar VMAT (using SmartArc) treatment plans were generated in Pinnacle(3) and compared. In addition, film measurements were performed using an anthropomorphic phantom to evaluate the skin dose for the different treatment techniques.
RESULTS: Using VMAT, the delivery times could be reduced to an average of 6.6 min compared with 23.7 min with noncoplanar IMRT. The mean dose to the healthy lung was 4.1 Gy for VMAT and noncoplanar IMRT and 4.2 Gy for coplanar IMRT. The volume of healthy lung receiving>5 Gy and >20 Gy was 18.0% and 5.4% for VMAT, 18.5% and 5.0% for noncoplanar IMRT, and 19.4% and 5.7% for coplanar IMRT, respectively. The dose conformity at 100% and 50% of the prescribed dose of 54 Gy was 1.13 and 5.17 for VMAT, 1.11 and 4.80 for noncoplanar IMRT and 1.12 and 5.31 for coplanar IMRT, respectively. The measured skin doses were comparable for VMAT and noncoplanar IMRT and slightly greater for coplanar IMRT.
CONCLUSIONS: Coplanar VMAT for SBRT for early-stage lung cancer achieved plan quality and skin dose levels comparable to those using noncoplanar IMRT and slightly better than those with coplanar IMRT. In addition, the delivery time could be reduced by ≤70% with VMAT.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21300461     DOI: 10.1016/j.ijrobp.2010.09.014

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  60 in total

Review 1.  Volumetric modulated arc therapy: a review of current literature and clinical use in practice.

Authors:  M Teoh; C H Clark; K Wood; S Whitaker; A Nisbet
Journal:  Br J Radiol       Date:  2011-11       Impact factor: 3.039

2.  Dosimetric effects of roll rotational setup errors on lung stereotactic ablative radiotherapy using volumetric modulated arc therapy.

Authors:  Jaegi Lee; Jung-In Kim; Sung-Joon Ye; Hak Jae Kim; Joel Carlson; Jong Min Park
Journal:  Br J Radiol       Date:  2015-09-15       Impact factor: 3.039

3.  Intensity-modulated radiotherapy and volumetric-modulated arc therapy have distinct clinical advantages in non-small cell lung cancer treatment.

Authors:  Jun Zhang; Xiao-Ling Yu; Guo-Feng Zheng; Fei Zhao
Journal:  Med Oncol       Date:  2015-03-01       Impact factor: 3.064

4.  FusionArc optimization: a hybrid volumetric modulated arc therapy (VMAT) and intensity modulated radiation therapy (IMRT) planning strategy.

Authors:  Martha M Matuszak; Jennifer M Steers; Troy Long; Daniel L McShan; Benedick A Fraass; H Edwin Romeijn; Randall K Ten Haken
Journal:  Med Phys       Date:  2013-07       Impact factor: 4.071

5.  Dosimetric evaluation of compensator intensity modulation-based stereotactic body radiotherapy for Stage I non-small-cell lung cancer.

Authors:  Y Tajima; H Nakayama; T Itonaga; S Shiraishi; M Okubo; R Mikami; S Sugahara; K Tokuuye
Journal:  Br J Radiol       Date:  2015-05-21       Impact factor: 3.039

6.  Stereotactic body radiation therapy vs. surgery in early-stage non-small cell lung cancer: lessons learned, current recommendations, future directions.

Authors:  Sibo Tian; Kristin A Higgins; Walter J Curran; Richard J Cassidy
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

Review 7.  Lung cancer. Radiotherapy in lung cancer: Actual methods and future trends.

Authors:  Adam Maciejczyk; Iga Skrzypczyńska; Marzena Janiszewska
Journal:  Rep Pract Oncol Radiother       Date:  2014-07-17

Review 8.  Advances in radiotherapy techniques and delivery for non-small cell lung cancer: benefits of intensity-modulated radiation therapy, proton therapy, and stereotactic body radiation therapy.

Authors:  Tejan P Diwanji; Pranshu Mohindra; Melissa Vyfhuis; James W Snider; Chaitanya Kalavagunta; Sina Mossahebi; Jen Yu; Steven Feigenberg; Shahed N Badiyan
Journal:  Transl Lung Cancer Res       Date:  2017-04

9.  Flattening filter-free technique in volumetric modulated arc therapy for lung stereotactic body radiotherapy: A clinical comparison with the flattening filter technique.

Authors:  Shuri Aoki; Hideomi Yamashita; Akihiro Haga; Kanabu Nawa; Toshikazu Imae; Wataru Takahashi; Osamu Abe; Keiichi Nakagawa
Journal:  Oncol Lett       Date:  2018-01-16       Impact factor: 2.967

10.  Planning benchmark study for SBRT of early stage NSCLC : Results of the DEGRO Working Group Stereotactic Radiotherapy.

Authors:  Christos Moustakis; Oliver Blanck; Fatemeh Ebrahimi Tazehmahalleh; Mark Ka Heng Chan; Iris Ernst; Thomas Krieger; Marciana-Nona Duma; Markus Oechsner; Ute Ganswindt; Christian Heinz; Horst Alheit; Hilbert Blank; Ursula Nestle; Rolf Wiehle; Christine Kornhuber; Christian Ostheimer; Cordula Petersen; Gerhard Pollul; Wolfgang Baus; Georg Altenstein; Eric Beckers; Katrin Jurianz; Florian Sterzing; Matthias Kretschmer; Heinrich Seegenschmiedt; Torsten Maass; Stefan Droege; Ulrich Wolf; Juergen Schoeffler; Uwe Haverkamp; Hans Theodor Eich; Matthias Guckenberger
Journal:  Strahlenther Onkol       Date:  2017-05-31       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.